Published in Sci Rep on February 23, 2016
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest. Sci Rep (2016) 0.78
2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis. Int J Oncol (2017) 0.78
Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival. Anticancer Res (2017) 0.75
ApoptomiRs of Breast Cancer: Basics to Clinics. Front Genet (2016) 0.75
Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation. Redox Biol (2017) 0.75
Attenuation of miR-34a protects cardiomyocytes against hypoxic stress through maintenance of glycolysis. Biosci Rep (2017) 0.75
PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res (2017) 0.75
MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. Biomed Res Int (2017) 0.75
MicroRNA regulation and analytical methods in cancer cell metabolism. Cell Mol Life Sci (2017) 0.75
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells. Sci Rep (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol (2005) 18.94
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Cancer's molecular sweet tooth and the Warburg effect. Cancer Res (2006) 7.24
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A (2008) 6.24
The miR-34 family in cancer and apoptosis. Cell Death Differ (2009) 5.92
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res (2009) 4.02
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res (2011) 3.25
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett (2008) 2.85
A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell (2013) 2.68
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discov (2012) 1.94
Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res (2010) 1.57
MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med (2012) 1.49
Cancer's sweet tooth. Cancer Cell (2006) 1.43
Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol (2013) 1.34
A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics (2010) 1.30
Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell (2013) 1.29
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.23
LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma. Tumour Biol (2012) 1.21
Genomic organization of human lactate dehydrogenase-A gene. Biochem J (1985) 1.18
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res (2011) 1.11
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget (2014) 1.11
Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene (2011) 1.11
Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Med Oncol (2012) 1.10
A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clin Cancer Res (2014) 1.10
Tumor suppressor microRNAs: a novel non-coding alliance against cancer. FEBS Lett (2014) 1.08
Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. Cancer Res (2014) 1.07
Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer (2014) 1.05
FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res (2014) 1.05
MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol (2014) 1.03
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget (2015) 1.01
Estrogen-related receptor alpha modulates lactate dehydrogenase activity in thyroid tumors. PLoS One (2013) 1.00
Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion. Mol Ther (2012) 1.00
MicroRNAs in the DNA Damage/Repair Network and Cancer. Int J Genomics (2014) 0.92
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma. J Cancer Res Ther (2015) 0.90
Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells. Oncotarget (2014) 0.87
Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil. Mol Med Rep (2014) 0.87
Embryonal carcinoma P19 cells produce erythropoietin constitutively but express lactate dehydrogenase in an oxygen-dependent manner. Blood (1998) 0.85